MinorEssential amino acid×Digestives. Multienzyme preparations
Updated · Methodology
Mechanism
Pancreatin acts only in the gut lumen: the enzymes are not absorbed intact but are digested like other proteins to peptides and amino acids (Kreon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). No interaction studies have been performed with pancreatin (Kreon SmPC, AEMPS, section 4.5). L-lysine is an essential amino acid. No medicine in Spain contains it as the active substance, and it is sold as a food supplement. In healthy women and people with osteoporosis, lysine 400–800 mg increased intestinal calcium absorption and reduced urinary calcium loss (Civitelli et al., 1992). Pancreatin does not reach the bloodstream and does not act on liver enzymes. This combination has not been studied, and no interaction mechanism is known.
Symptoms
No symptoms caused by this combination have been described. Fibrosing colonopathy has been reported in people with cystic fibrosis taking high doses of pancreatin, and anaphylactic reactions are rare. Chewing the capsules or holding them in the mouth can irritate the oral mucosa (Kreon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). In a systematic review of 71 studies with 3357 participants, lysine's adverse events were mainly gastrointestinal, and their risk did not differ significantly from control (Hayamizu et al., 2020).
Management
The combination can be used and no dose change is needed. There are no data on an interaction, and no mechanism that would cause one is known (Kreon SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, sections 4.5 and 5.2). Pancreatin capsules should not be chewed or held in the mouth. Unusual or changing abdominal symptoms are assessed to rule out fibrosing colonopathy, especially in people with cystic fibrosis taking more than 10 000 lipase units per kilogram per day (Kreon SmPC, AEMPS, section 4.4). The review authors set a provisional no-observed-adverse-effect level of 6 g of lysine a day in healthy adults (Hayamizu et al., 2020).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Pancreatina, Kreon 35.000 U (nº registro 83862), sección 4.5 (2026)– AEMPS, CIMA, nº registro 83862 (Kreon 35.000 U cápsulas duras gastrorresistentes, Viatris), revisión 09/2026, secciones 4.4, 4.5 y 5.2
- Nutrition: Dietary L-lysine and calcium metabolism in humans (1992)– Civitelli R, et al. Nutrition. 1992;8(6):400-5. PMID 1486246
- The Journal of nutrition: Comprehensive Safety Assessment of l-Lysine Supplementation from Clinical Studies: A Systematic Review (2020)– Hayamizu K, Oshima I, Nakano M. J Nutr. 2020;150(Suppl 1):2561S-2569S. PMID 33000161